← FDA DRUG APPROVALS

FDA ANDA · ANDA200935

CALCIPOTRIENE

Sponsor: CHARTWELL RX

APPLICATION
ANDA200935
TYPE
ANDA
ORIGINAL APPROVAL
2012-05-30
LATEST ACTION
2019-10-22
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

CALCIPOTRIENEDiscontinued
CALCIPOTRIENE 0.005% · CREAM · TOPICAL

Approval history

2019-10-22Labeling · Supplement 3 · standardAP
2012-05-30Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →